Single injection results of endoscopic treatment of vesicoureteric reflux with different tissue-bulking substances in patients with end stage renal failure

Journal of Endourology

Volumn 25, Issue 5, 2011, Pages 831-835

  Dirim, Ayhan ^a   Hasirci, Eray ^a   Turunc, Tahsin ^a   Aygun, Cem ^a   Ozkardes, Hakan ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

COPOLYMER; DEXTRANOMER; DEXTRANOMER HYALURONIC ACID COPOLYMER; DIMETICONE; HYALURONIC ACID; HYDROXYAPATITE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CHILD; COMPARATIVE EFFECTIVENESS; DISEASE SEVERITY; ENDOSCOPIC THERAPY; FEMALE; HUMAN; INJECTION SITE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SUBURETERAL INJECTION; TREATMENT OUTCOME; URETER; URETHRAL CATHETERIZATION; UROLOGIC EXAMINATION; VESICOURETERAL REFLUX; VOIDING CYSTOURETROGRAPHY;

ADOLESCENT; ADULT; CHILD; DEXTRANS; DIMETHYLPOLYSILOXANES; DURAPATITE; ENDOSCOPY; FEMALE; HUMANS; HYALURONIC ACID; INJECTIONS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; TREATMENT OUTCOME; VESICO-URETERAL REFLUX; YOUNG ADULT;

EID: 79957617386     PISSN: 08927790     EISSN: 1557900X     Source Type: Journal    
DOI: 10.1089/end.2010.0440     Document Type: Article

References (22)

1. Schulman CC, Pamart D, Hall M, et al. Vesicoureteral reflux in children: Endoscopic treatment. Eur Urol 1990;17:314-317. (Pubitemid 20182254)
2. Joyner BD, Atala A. Endoscopic substances for the treatment of vesicoureteral reflux. Urology 1997;50:489-494. (Pubitemid 27433204)
3. Puri P, Granata C. Multicenter surgery of endoscopic treatment of vesicoureteral reflux using polytetrafluoroethylene. J Urol 1998;160:1007-1011. (Pubitemid 29477735)
4. Mevorach RA, Hulbert WC, Rabinowitz R, et al. Results of a 2-year multicenter trial of endoscopic treatment of vesicoureteral reflux with synthetic calcium hydroxyapatite. J Urol 2006;175:288-291. (Pubitemid 41797181)
5. Mayer R, Lightfoot M, Jung I. Preliminary evaluation of calcium hydroxylapatite as a transurethral bulking agent for stress urinary incontinence. Urology 2001;57:434-438. (Pubitemid 32192968)
6. Eryildirim B, Tarhan F, Kuyumcuog? lu U, et al. Endoscopic subureteral injection treatment with calcium hydroxylapatite in primary vesicoureteral reflux. Int Urol Nephrol 2007; 39:417-420. (Pubitemid 47054837)
7. Tarcan T, Tinay I, Temiz Y, Simsxek F. Long-term results of endoscopic treatment of vesicoureteral reflux with the subureteric injection of calcium hydroxyapatite. Int Urol Nephrol 2007;39:1011-1114.
8. Mora Durbán MJ, Navarro Sebastián FJ, Mun̈oz Delgado MB, et al. [Endoscopic treatment of the vesicoureteral reflux in children: Preliminary experience with the subureteral injection of Coaptite.] (Spa) Arch Esp Urol 2006;59:493-499. (Pubitemid 44084908)
9. Stenberg A, Larsson E, Lindholm A, et al. Injectable dextranomer- based implant: Histopathology, volume changes and DNA-analysis. Scand J Urol Nephrol 1999;33:355-361. (Pubitemid 30017030)
10. Puri P, Pirker M, Mohanan N, et al. Subureteral dextranomer/ hyaluronic acid injection as first line treatment in the management of high grade vesicoureteral reflux. J Urol 2006;176:1856-1860. (Pubitemid 44291732)
11. Elder JS, Shah MB, Batiste LR, Eaddy M. Part 3: Endoscopic injection versus antibiotic prophylaxis in the reduction of urinary tract infections in patients with vesicoureteral reflux. Curr Med Res Opin 2007;23(suppl 4):S15-S20. (Pubitemid 350022264)
12. Kirsch AJ, Perez-Brayfield MR, Scherz HC. Minimally invasive treatment of vesicoureteral reflux with endoscopic injection of dextranomer/hyaluronic acid copolymer: The Children's Hospitals of Atlanta experience. J Urol 2003;170:211-215. (Pubitemid 36734464)
13. Puri P, Chertin B, Velayudham M, et al. Treatment of vesicoureteral reflux by endoscopic injection of dextranomer/ hyaluronic Acid copolymer: Preliminary results. J Urol 2003; 170:1541-1544. (Pubitemid 37102403)
14. Chertin B, Colhoun E, Velayudham M, Puri P. Endoscopic treatment of vesicoureteral reflux: 11 to 17 years of followup. J Urol 2002;167:1443-1445. (Pubitemid 34132127)
15. Guerra LA, Khanna P, Levasseur M, et al. Endoscopic treatment of vesicoureteric reflux with Deflux: A Canadian experience. Can Urol Assoc J 2007;1:41-45.
16. Smith DP, Kaplan WE, Oyasu R. Evaluation of polydimethylsiloxane as an alternative in the endoscopic treatment of vesicoureteral reflux. J Urol 1994;152:1221-1224. (Pubitemid 24283482)
17. Choo MS, Hong B, Ji YH, et al. Endoscopic treatment of vesicoureteral reflux with polydimethylsiloxane in adult women. Eur Urol 2004;45:787-789. (Pubitemid 38638401)
18. Bartoli F, Niglio F, Gentile O, et al. Endoscopic treatment with polydimethylsiloxane in children with dilating vesicoureteric reflux. BJU Int 2006;97:805-808. (Pubitemid 43383519)
19. Lorenzo AJ, Pippi Salle JL, Barroso U, et al. What are the most powerful determinants of endoscopic vesicoureteral reflux correction? Multivariate analysis of a single institution experience during 6 years. J Urol 2006;176:1851-1855. (Pubitemid 44291711)
20. Alkan M, Ciftci AO, Senocak ME, et al. Endoscopic treatment of vesicoureteral reflux in children: Our experience and analysis of factors affecting success rate. Urol Int 2008;81: 41-46.
21. Oswald J, Riccabona M, Lusuardi L, et al. Prospective comparison and 1-year follow-up of a single endoscopic subureteral polydimethylsiloxane versus dextranomer/ hyaluronic acid copolymer injection for treatment of vesicoureteral reflux in children. Urology 2002;60:894-898.
22. Lavelle MT, Conlin MJ, Skoog SJ. Subureteral injection of Deflux for correction of reflux: Analysis of factors predicting success. Urology 2005;65:564-567. (Pubitemid 40386010)